Intervention for Sexual and Biomedical HIV Prevention in Vulnerable U.S. Young Adults

Description

The study team will conduct a two-group study to examine the efficacy of implementing an enhanced microenterprise intervention to improve economic stability and HIV preventive behaviors. The team will enroll approximately 780 young adults. Participants will be randomly assigned to one of two groups. The first group ("control") will receive text messages with information on job openings. The second group ("intervention") will receive text messages with information on job openings plus HIV prevention and employment educational sessions, mentorship, a micro-grant, and HIV behavioral economics text messages.

Conditions

Economic Hardship, Condomless Sex, Utilization, Health Care

Study Overview

Study Details

Study overview

The study team will conduct a two-group study to examine the efficacy of implementing an enhanced microenterprise intervention to improve economic stability and HIV preventive behaviors. The team will enroll approximately 780 young adults. Participants will be randomly assigned to one of two groups. The first group ("control") will receive text messages with information on job openings. The second group ("intervention") will receive text messages with information on job openings plus HIV prevention and employment educational sessions, mentorship, a micro-grant, and HIV behavioral economics text messages.

Microenterprise and Behavioral Economics Intervention for Sexual and Biomedical HIV Prevention in Vulnerable U.S. Young Adults (EMERGE)

Intervention for Sexual and Biomedical HIV Prevention in Vulnerable U.S. Young Adults

Condition
Economic Hardship
Intervention / Treatment

-

Contacts and Locations

Baltimore

Johns Hopkins University, Baltimore, Maryland, United States, 21205

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    18 Years to 24 Years

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    Yes

    Collaborators and Investigators

    University of North Carolina, Chapel Hill,

    Larissa Jennings Mayo-Wilson, PhD MHS, PRINCIPAL_INVESTIGATOR, University of North Carolina, Chapel Hill

    Adriana Parker, MPH, STUDY_DIRECTOR, University of North Carolina, Chapel Hill

    Study Record Dates

    2027-03-31